Harvey Jones

Harvey is a Chartered Accountant and has more that thirty years experience, qualifying in the UK before moving to Australia in 1999. Harvey has held senior finance roles in industry and is currently the CFO of an advanced manufacturing business. Harvey has an MBA from the Australian Graduate School of Management. Outside of work Harvey […]
Leave Jimmy a message!
Identification of the genetic causes of Fanconi anaemia

We are studying the genetic causes of Fanconi anaemia and similar conditions. Knowing which gene variant(s) is causing FA in an individual, or runs in a family, is useful because: To participate or for more information, contact research@fasa.org.au
Amelia Hawkshaw

My name is Amelia and I live in Sydney, Australia. I was diagnosed with FA in 2016 when I was 23. It was identified after I had chemotherapy for bowel cancer, and my body reacted pretty negatively to it! I haven’t been transplanted. I have a team of doctors at Chris O’Brien LifeHouse in Sydney […]
Dr. Wayne Crismani

Wayne is a researcher at St Vincent’s Institute of Medical Research (SVI) in Melbourne. His team is focused on understanding Fanconi anaemia and he is passionate about making a difference to people affected by FA through fundamental research and through FASA. Wayne, Hannah Fluhler and a large team of experts have a research study open, […]
Alan Howard-Jones

Alan is the Treasurer, and lives in Adelaide, South Australia. Alan has been connected to the Fanconi Anaemia community since 1998 when he married his late wife Charisse, an FA adult (now deceased). Alan has over 25 year’s working experience in the private sector, covering business management and administration, customer engagement and technical support roles […]
Barbara & Chris Hawkshaw

Barbara is president of FASA and has a background in nursing and Public Health. Chris, the secretary, is a TV writer. We had not heard of Fanconi Anaemia until our daughter Amelia was diagnosed at age 23, following surgery for bowel cancer and a catastrophic brush with chemotherapy. That was in 2016.Our learning curve was […]
Clinical study: Preventative screening of oral lesions in Fanconi Anaemia patients in Australia

The diagnostic accuracy and safety have been demonstrated of a non-invasive brush biopsy of visible oral lesions analysed with cytology analysis in the FA population. This was a large prospective study carried out in Germany by Heinrich Heine University together with the German support group (Fanconi Hilfe). Based on these findings that oral cancer can […]
DNA repair & recombination

Our vision is to translate basic knowledge of DNA repair pathways to treatments for cancer, bone marrow failure syndromes, and infertility. FANCM (Fanconi anemia complementation (FANC) group M) is a protein that can remodel a range of unique DNA structures, particularly structures that occur during DNA replication and repair. Similarly, FANCM is important to keep […]
The role of FANCM, a gene mutated in Fanconi Anaemia

Fanconi anaemia is an inherited disorder with greatly elevated risk of leukaemia and cancers. A causal gene called FANCM is a ‘tumour suppressor’. Our work is uncovering its tumour suppressor function: a complex function in repair of damage to our DNA. This study aims to understand how this protects us from cancer, and may influence […]